Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Pepinemab by Vaccinex for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
Pepinemab is under clinical development by Vaccinex and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase...
Pepinemab by Vaccinex for Solid Tumor: Likelihood of Approval
Pepinemab is under clinical development by Vaccinex and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
Pepinemab by Vaccinex for Osteosarcoma: Likelihood of Approval
Pepinemab is under clinical development by Vaccinex and currently in Phase II for Osteosarcoma. According to GlobalData, Phase II drugs...